FOXO1 overexpression enhanced CAR T cell efficacy as indicated by a significant decrease in tumour mass (Fig. 5a), which was associated with a significant increase in the number of CD8+ and CD4+ CAR T cells in the blood and spleen of treated mice (Fig. 5b,c). The gene discussed is CD4; the disease is neoplasm.